Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/ejzrCrsecrBbsQldsGlA

  ADVERTISEMENT  
February 8, 2013News for the transfusion medicine and cellular therapy community

  Top Story 
 
 
  ADVERTISEMENT  
Digi-Trax® Corporation Helps Ensure your Facility's FDA Compliance
HemaTrax-UNITY is our newest blood bank software for printing ISBT 128 compliant labels. It works with your BBIS and can also be used as a standalone system - very useful for disaster recovery. Our single-source solution combines HemaTrax-UNITY software with printers, scanners, validation, labels and service. Learn more.

  Science & Health 
  • Study suggests interferon not effective in hepatitis C relapse
    Interferon monotherapy may not be the best retreatment for patients with hepatitis C and chronic liver disease who relapse after initial therapy or do not respond to it at all, according to a study from the University of California, Los Angeles. Researchers said study data showed higher risk of all-cause mortality among patients, and they also found evidence of more pain and adverse effects among the group treated with interferon. The researchers said their findings also raised questions about common biomarkers, including sustained viral response, because levels improved even when outcomes did not. Medscape (free registration) (1/30), DailyRx.com (2/5) LinkedInFacebookTwitterEmail this Story
  Emerging Trends 
  • Sequester could slow or stop FDA reviews, analyst warns
    FDA operations will be limited by budget sequestration if lawmakers don't move to stop an 8.2% automatic cut before March 1, the consulting firm Avalere Health warned. "An underfunded FDA could lead to FDA review clocks being reset or delayed, which would affect a sponsor's ability to obtain product approval -- thus delaying patient access to cutting edge medical innovations," Avalere said in its report. The Hill/Healthwatch blog (2/5) LinkedInFacebookTwitterEmail this Story
  Industry News & Practice 
  • BioAegis raises $3 million
    A funding round has brought in $3 million for biotech startup BioAegis Therapeutics. The company plans to file an investigational new-drug application with the FDA and launch a Phase IIb/III study of human plasma gelsolin, a natural human protein, in preventing the spread of inflammation resulting in multiple organ dysfunction syndrome in intensive care units. American City Business Journals/Boston/bioflash blog/Mass High Tech (2/7) LinkedInFacebookTwitterEmail this Story
  Government & Regulatory 
  • Bill would create a National Nurse for Public Health position
    House lawmakers introduced the National Nurse Act to name the U.S. Public Health Service's chief nurse officer as the National Nurse for Public Health to work alongside the surgeon general. Rep. Eddie Bernice Johnson, D-Texas, who is a registered nurse, said nurses "play a critical role in health promotion and disease prevention." The Hill/Floor Action blog (2/5) LinkedInFacebookTwitterEmail this Story
  • Legislators introduce bill aimed at repealing device tax
    A bill that would repeal the 2.3% medical device tax has been introduced by Reps. Erik Paulsen, R-Minn., and Ron Kind, D-Wis., along with more than 170 co-sponsors. The legislators said the tax could stymie economic growth and job creation in the medtech sector, which provides more than 400,000 jobs in the U.S. A companion bill is expected to follow in the Senate soon. AuntMinnie.com (free registration) (2/6) LinkedInFacebookTwitterEmail this Story
  Association News 
  • AABB Live Learning Center offers CME/CE credits
    Individuals are encouraged to visit AABB's Live Learning Center to earn CME/CE credits. The center offers easy access to essential Annual Meeting information, centralized audioconference registration and CME/CE tracking and attendance certification. Learn More. LinkedInFacebookTwitterEmail this Story
Learn more about AABB® ->Homepage  |  Join AABB  |  Conferences  |  Marketplace

Position TitleCompany NameLocation
Donor Collections DirectorBlood Centers of the PacificUS - CA - San Francisco
Medical Technologist CLS - Cord Blood ProgramSan Diego Blood BankUS - CA - San Diego
Director, Regional Technical Services at Community Blood BankUnited Blood ServicesUS - NV - Las Vegas
CLINICAL LABORATORY SCIENTISTBlood Centers of the PacificUS - CA - San Francisco
Click here to view more job listings.

  SmartQuote 
If you want to make enemies, try to change something."
--Woodrow Wilson,
28th U.S. president


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Corporate Relations Manager:  Tamara Zein (240) 333-6604
Job Board: AABB CareerLink
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent AABB SmartBrief Issues:   Lead Editor:  Tom Parks
Managing Editor: Jennifer Garfinkel

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information